[[(1,1-dimethylethoxy)carbonyl]amino]-2,4,5-trifluoro-(R)-benzenebutanoic acid CAS:486460-00-8

[[(1,1-dimethylethoxy)carbonyl]amino]-2,4,5-trifluoro-(R)-benzenebutanoic acid finds applications in pharmaceutical research as a building block for synthesizing bioactive compounds. Its structural components can be modified to create analogs with diverse biological properties, such as enzyme inhibition, receptor modulation, or antimicrobial effects. Researchers use this compound to design novel drug candidates with improved pharmacokinetic profiles and target specificity. By incorporating [[(1,1-dimethylethoxy)carbonyl]amino]-2,4,5-trifluoro-(R)-benzenebutanoic acid into molecular structures, scientists aim to enhance drug potency, selectivity, and metabolic stability. The compound's trifluoromethyl and carboxylic acid moieties play essential roles in its interactions with biological targets, potentially leading to therapeutic benefits. Studies focus on understanding its mechanism of action, safety profile, and efficacy in preclinical models to evaluate its potential for clinical applications. Through synthetic modifications and structure-activity relationship studies, researchers explore the pharmacological relevance of [[(1,1-dimethylethoxy)carbonyl]amino]-2,4,5-trifluoro-(R)-benzenebutanoic acid derivatives. These investigations aim to identify lead compounds for treating various diseases, including cancer, inflammation, or metabolic disorders. Overall, [[(1,1-dimethylethoxy)carbonyl]amino]-2,4,5-trifluoro-(R)-benzenebutanoic acid serves as a versatile scaffold for designing biologically active molecules with potential therapeutic applications. Its role in medicinal chemistry research contributes to the discovery of innovative drugs and advances in the treatment of complex medical conditions, highlighting its significance in drug development.